NCT00483158View on ClinicalTrials.gov

First Time in Man Study of Finafloxacin Hydrochloride

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Helicobacter InfectionsUrinary Tract Infection
Interventions
DRUG

Finafloxacin hydrochloride

Tablets, oral single dose and multiple dose once daily for 7d

Trial Locations (1)

CH-4123

Swiss Pharma Contract Ltd, Basel

Sponsors
All Listed Sponsors
lead

MerLion Pharmaceuticals GmbH

INDUSTRY

NCT00483158 - First Time in Man Study of Finafloxacin Hydrochloride | Biotech Hunter | Biotech Hunter